Recently approved medicare provisions for prescription drugs and medication management services

Journal of Pharmacy Technology

Volumn 21, Issue 2, 2005, Pages 63-68

  Powers, Mary F ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANTIOBESITY AGENT; ANTITUSSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; COSMETIC; DESIGNER DRUG; FERTILITY PROMOTING AGENT; FLUORIDE; INSULIN; MINERAL; NON PRESCRIPTION DRUG; VITAMIN;

DRUG COST; DRUG DISCOUNT CARD; DRUG LEGISLATION; HEALTH CARE MANAGEMENT; MEDICARE; MEDICARE PRESCRIPTION DRUG IMPROVEMENT AND MODERNIZATION ACT; MEDICATION MANAGEMENT SERVICE; PHARMACOECONOMICS; PHARMACY; REIMBURSEMENT; REVIEW;

EID: 14644414198     PISSN: 87551225     EISSN: None     Source Type: Journal    
DOI: 10.1177/875512250502100203     Document Type: Review

References (11)

1. CMS/HCFA history. www.cms.hhs.gov/about/history/ (accessed 2004 Apr 3).
2. Gluck MG, Reno V, eds. Reflections on implementing Medicare. Washington, DC: National Academy of Social Insurance, January 2001.
3. Medicare Prescription Drug Improvement and Modernization Act of 2003. http://frwebgate.access.gpo.gov/cgi-bin/getdoc. cgi?dbname= 108_cong_bills&docid=f:h1enr.txt.pdf (accessed 2004 Apr 3).
4. Centers for Medicare and Medicare Services general glossary www.cms.hhs.gov/glossary/default.asp?Letter=ALL&Language= English#Content (accessed 2004 Apr 3).
5. Medicare Prescription Drug Discount Card, Interim Rule and Notice. 68 Federal Register 69840 (2003) (codified at 42 CFR Parts 403, 408). www.cms.hhs.gov/providerupdate/regs/cms4063ifc.pdf (accessed 2004 Apr 2).
6. SEC. 1927.[42 U.S.C. 1396r-8]. wwwssa.gov/OP_Home/ssact/title19/ 1927.htm (accessed 2004 Apr 3).
7. Approved drug card sponsor lists. www.cms.hhs.gov/ medicarereform/ drugcard/sponsorinfo/ (accessed 2004 Jun 17).
8. Medicare Prescription Drug Discount Card and Transitional Assistance Program [fact sheet]. www.cmshhs.gov/media/press/release. asp?Counter=990 (accessed 2004 Apr 3).
9. Meyer BM, Cantwell KM. The Medicare Prescription Drug Improvement and Modernization Act of 2003: implications for health-system pharmacy. Am J Health Syst Pharm 2004;61:1042-51.
10. Conference Report compared with APhA key principles. www. aphanet.org/govt/hs_comparison.pdf (accessed 2004 Apr 3).
11. Section 101, Subpart 2, Sec. 1860D-4 (c), cost and utilization management; quality assurance; Medication Therapy Management Program, page 32 of H.R. 1 Conference Report. http://frwebgate. access.gpo.gov/cgi-bin/getdoc.cgi? dbname=108_cong_bills& docid=f:h1enr.txt.pdf (accessed 2005 Feb 1).